Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00658047Phase 2Completed
A Phase 2 trial of ch-1504 in rheumatoid arthritis (RA), sponsored by Chelsea Therapeutics International, Ltd.. Started Apr 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00658047.